Lactate Dehydrogenase isoenzyme 1 (LD1)
Author: Larry Bernstein, M.D., Triplex Consulting (see Reviewers/Authors page)
Revised: 12 December 2010, last major update December 2010
Copyright: (c) 2003-2010, PathologyOutlines.com, Inc.
● LDH measures the amount of serum lactate dehydrogenase (LDH), which is released into the circulation with an acute myocardial infarction (AMI) due to tissue damage
● LDH is elevated on the second day after chest pain and remains elevated for up to 4 days
● LD1 is the heart specific form of the enzyme present in AMI between 12 and 24 hours after onset of chest pain
● LDH is an enzyme (EC 18.104.22.168) ubiquitous in tissue
● It has five isoenzymes, each with a different composition of M-type and H-type subunits in a tetrameric structure
● LD1 (HHHH) is present in cardiac muscle and erythrocytes
● LD2 is usually the predominant form in serum
● In acute myocardial infarction, the serum levels of LD1 are greater than LD2 (a "flipped pattern")
● However, the use of LD1 to diagnose AMI has been largely superseded by Troponin I or T
● The isoenzyme 1 of LD is measured by immunoprecitation of LD 2-5 and measuring the residual activity; also by electrophoresis and staining of agarose media
● Patients presenting 12+ hours after the onset of chest pain or other symptoms suggestive of an acute myocardial infarction
● The LD1 isoenzyme typically is elevated in acute renal failure and with hemolytic anemia
● Must interpret values in context of clinical findings
End of Clinical Chemistry > Cardiac-related tests > Lactate Dehydrogenase isoenzyme 1 (LD1)
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).